InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid Stenting (CAS) to Include Both Asymptomatic and Standard Risk Patients
Provides additional treatment options for patients and treating physicians; likely expands CAS addressable market Potentially accelerates conversion of ...